Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan ...

All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne ...

The pioneering DNA testing firm 23andMe is in turmoil. Seven independent members of the company’s eight-person board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki ...

The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...

To get it in your inbox, sign up for free, here. New York CNN — The history of DNA-testing startup 23andMe reads like a formula for a screenplay set in turn-of-the-century Silicon Valley ...

Wojcicki co-founded 23andMe – known for its saliva DNA testing and digital ancestry tools – in 2006. 23andMe shares have plummeted 96.6% since it went public in 2021 — trading at $0.35 on ...

DNA test sales have dropped off ... Once valued at $3.5 billion, 23andMe’s market cap now hovers below $200 million. Nonetheless, the drug development and genetic sequencing that the firm ...

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

The history of DNA-testing startup 23andMe (ME) reads like a formula for a screenplay set in turn-of-the-century Silicon Valley: A Yale grad grows tired of hedge fund life and returns to her roots ...